Your AI-Trained Oncology Knowledge Connection!


Video

Dr. Oh on Recognizing Symptom Burden in Advanced Prostate Cancer

William K. Oh, MD, professor of Medicine, Hematology, and Medical Oncology, and Urology, Mount Sinai Hospital, discusses a global study aimed at recognizing symptom burden in patients with advanced prostate cancer.

William K. Oh, MD, professor of Medicine, Hematology, and Medical Oncology, and Urology, Mount Sinai Hospital, discusses a global study aimed at recognizing symptom burden in patients with advanced prostate cancer.

Over 900 patients and their caregivers were surveyed in 11 countries, Oh explains. Findings showed that patients are underreporting symptoms and harbor a significant symptom burden with advanced disease. There are also differences in reported symptoms by country, as well as a discrepancy between patients and their caregivers on whether their symptoms are negatively impacting their daily activities.

The cause of this lack of reporting, Oh says, is likely because many men feel uncomfortable or believe it is a "sign of weakness" to report their symptoms. However, Oh adds, it is important for men to discuss symptoms with their physicians as they may be able to improve them.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Related Videos
Timothy S. Fenske, MD, MS
Sheela Rao, MBBS, MD, FRCP
Yufei Liu, MD, PhD
Seema A. Bhat, MD, a hematologist at The Ohio State University Comprehensive Cancer Center—James; as well as an assistant professor in the Department of Internal Medicine in the Division of Hematology at The Ohio State University
Jacob Moyer, BS, of Mayo Clinic
Alfred L. Garfall, MD
COOMBS
Dr Fakih on the Future of Botensilimab and Balstilimab–Based Therapies in MSS mCRC
Alberto Montero, MD, MBA, CPHQ
Elizabeth Lee, MD, a gynecologic oncologist and the gynecologic oncology program's liaison to the Center for Cancer Therapeutics Innovation at Dana-Farber Cancer Institute